WO2002069936A3 - Composition pharmaceutique amelioree d'ibuprofene et procede de production de telles compositions - Google Patents

Composition pharmaceutique amelioree d'ibuprofene et procede de production de telles compositions Download PDF

Info

Publication number
WO2002069936A3
WO2002069936A3 PCT/IB2002/000534 IB0200534W WO02069936A3 WO 2002069936 A3 WO2002069936 A3 WO 2002069936A3 IB 0200534 W IB0200534 W IB 0200534W WO 02069936 A3 WO02069936 A3 WO 02069936A3
Authority
WO
WIPO (PCT)
Prior art keywords
soft gelatin
ibuprofen
active ingredient
gelatin capsule
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2002/000534
Other languages
English (en)
Other versions
WO2002069936A2 (fr
Inventor
Prashant Manohar Mandaogade
Ujwal Damu Kolhe
Abhijit Mukund Deshmukh
Mailatur Sivaraman Mohan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dr Reddys Laboratories Ltd
Original Assignee
Dr Reddys Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Reddys Laboratories Ltd filed Critical Dr Reddys Laboratories Ltd
Priority to AU2002244865A priority Critical patent/AU2002244865A1/en
Publication of WO2002069936A2 publication Critical patent/WO2002069936A2/fr
Publication of WO2002069936A3 publication Critical patent/WO2002069936A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention concerne un principe actif, l'ibuprofène ou (S)(+)-ibuprofène en tant que base libre ou en tant que sels de métal alcalin, ou que de mélanges desdits composants, sous forme d'une capsule en gélatine molle, lesdites capsules en gélatine molle présentant une composition de masse de gel de capsule en gélatine molle permettant de favoriser la solubilisation du principe actif. L'invention concerne également le procédé de production d'une telle capsule en gélatine molle ou d'une telle composition de masse de gel de gélatine molle. Un autre aspect de l'invention permet d'éviter l'utilisation de polyéthylène glycol ou d'espèces d'ions hydroxydes contenant des solvants en tant que solubilisateurs, pour la préparation de capsules en gélatine molle contenant ledit principe actif.
PCT/IB2002/000534 2001-03-02 2002-02-22 Composition pharmaceutique amelioree d'ibuprofene et procede de production de telles compositions Ceased WO2002069936A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002244865A AU2002244865A1 (en) 2001-03-02 2002-02-22 Pharmaceutical composition of ibuprofen

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN187MA2001 2001-03-02
IN187/MAS/2001 2001-03-02
IN204MA2001 2001-03-07
IN204/MAS/2001 2001-03-07

Publications (2)

Publication Number Publication Date
WO2002069936A2 WO2002069936A2 (fr) 2002-09-12
WO2002069936A3 true WO2002069936A3 (fr) 2003-02-20

Family

ID=26324890

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2002/000534 Ceased WO2002069936A2 (fr) 2001-03-02 2002-02-22 Composition pharmaceutique amelioree d'ibuprofene et procede de production de telles compositions

Country Status (2)

Country Link
AU (1) AU2002244865A1 (fr)
WO (1) WO2002069936A2 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107875117A (zh) * 2011-04-11 2018-04-06 维特斯集团 口服药物分散组合物
US10966926B2 (en) 2010-04-14 2021-04-06 Vitux Group As Oral pharmaceutical dispersion compositions

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2404336A (en) * 2003-07-30 2005-02-02 Cipla Ltd Stabilisation of therapeutic agents using a carbonate salt of an amino acid, preferably in the presence of a saccharide, & pharmaceutical compositions thereof
WO2005063219A2 (fr) * 2003-12-23 2005-07-14 Ranbaxy Laboratories Limited Capsules en gelatine molle contenant de l'ibuprofene
EP2037898A2 (fr) * 2006-06-30 2009-03-25 Mcneil-PPC, Inc Capsules dures emplies d'un liquide contenant de l'ibuprofène
US20080113021A1 (en) * 2006-10-25 2008-05-15 Robert Shen Ibuprofen composition
WO2009069139A1 (fr) * 2007-11-28 2009-06-04 Alkem Laboratories Ltd. Forme posologique fournissant un remplissage liquide contenant de l'ibuprofène
CN102204882B (zh) * 2011-03-22 2013-07-24 韩彬 布洛芬的药物组合物

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4834966A (en) * 1986-08-01 1989-05-30 Zambon S.P.A. Pharmaceutical composition with analgesic activity
US5376688A (en) * 1992-12-18 1994-12-27 R. P. Scherer Corporation Enhanced solubility pharmaceutical solutions
US5645856A (en) * 1994-03-16 1997-07-08 R. P. Scherer Corporation Delivery systems for hydrophobic drugs
WO1998038984A2 (fr) * 1997-03-05 1998-09-11 Sugen, Inc. Preparations d'agents pharmaceutiques hydrophobes
US5858401A (en) * 1996-01-22 1999-01-12 Sidmak Laboratories, Inc. Pharmaceutical composition for cyclosporines
GB2331458A (en) * 1997-11-21 1999-05-26 Gursharan Singh Moonga Solvent compositions for gelatin capsules

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4834966A (en) * 1986-08-01 1989-05-30 Zambon S.P.A. Pharmaceutical composition with analgesic activity
US5376688A (en) * 1992-12-18 1994-12-27 R. P. Scherer Corporation Enhanced solubility pharmaceutical solutions
US5645856A (en) * 1994-03-16 1997-07-08 R. P. Scherer Corporation Delivery systems for hydrophobic drugs
US5858401A (en) * 1996-01-22 1999-01-12 Sidmak Laboratories, Inc. Pharmaceutical composition for cyclosporines
WO1998038984A2 (fr) * 1997-03-05 1998-09-11 Sugen, Inc. Preparations d'agents pharmaceutiques hydrophobes
GB2331458A (en) * 1997-11-21 1999-05-26 Gursharan Singh Moonga Solvent compositions for gelatin capsules

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10966926B2 (en) 2010-04-14 2021-04-06 Vitux Group As Oral pharmaceutical dispersion compositions
CN107875117A (zh) * 2011-04-11 2018-04-06 维特斯集团 口服药物分散组合物

Also Published As

Publication number Publication date
AU2002244865A1 (en) 2002-09-19
WO2002069936A2 (fr) 2002-09-12

Similar Documents

Publication Publication Date Title
GB2210879B (en) 4h-1-benzopyran-4-one derivative or its salt, process for producing the same and pharmaceutical composition comprising the same as active ingredient
IL139825A0 (en) Novel cyclosporins
IE893564L (en) Novel 3-piperidinyl-1,2-benzisoxazoles
HUP0104495A2 (hu) N-szubsztituált 2-ciano-pirrolidinek és ezeket tartalmazó gyógyászati készítmények
MXPA03011041A (es) Composiciones farmaceuticas que contienen orlistat y acidos grasos y/o sales de los mismos.
ES8602763A1 (es) Un procedimiento para la preparacion de n-(heterociclilbiciclo)-4-piperidinaminas.
EA200300104A1 (ru) НОВАЯ γ КРИСТАЛЛИЧЕСКАЯ ФОРМА ТРЕТ-БУТИЛАМИНОВОЙ СОЛИ ПЕРИНДОПРИЛА, СПОСОБ ЕЕ ПОЛУЧЕНИЯ И СОДЕРЖАЩИЕ ЕЕ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ
AU2232288A (en) Novel substituted n-(1-alkyl-3-hydroxy-4-piperidinyl) benzamides
PA8559401A1 (es) Sales de acido succinico de 5,7,14-triazatetraciclo (10.3.1.0 2,11.0 4, 9)-hexadeca-2 (11),3,5,7,9-pentaeno y composiciones farmaceuticas de las mismas.
GEP20063926B (en) Pharmaceutical compositions of amlodipine and atorvastatin
CA2335551A1 (fr) Analogues des hormones thyroidiennes et methodes de preparation associees
BR0317567A (pt) Composição farmacêutica de liberação controlada de tamsulosina e processo para sua preparação
PL348419A1 (en) Sustained-release pharmaceutical preparation containing tilidine mesylate as active ingredient
EP0353821A3 (fr) Dérivés du 3-pipérazinyl-benzazole antipsychotiques
WO2001080619A3 (fr) Composition pharmaceutique contenant du citalopram
CA2494321A1 (fr) Derive de 1,2,4-triazole, son procede de preparation et composition pharmaceutique le contenant
WO2005063219A3 (fr) Capsules en gelatine molle contenant de l'ibuprofene
BR0311642A (pt) Formulação de divalproex de sódio de liberação aumentada
DK440888A (da) Hjaelpestoffer som resorptionsfremmende stoffer af peptider og proteiner ved paafoering paa slimhinder samt anvendelse deraf g praepparat indeholdende hjaelpestofferne
HUP0004701A2 (hu) Új dezloratadin sók, az ezeket tartalmazó gyógyászati készítmények és eljárás azok előállítására
YU72802A (sh) Farmaceutske smeše koje sadrže oligosaharide, novi oligosaharidi i njihovo dobijanje
CA2127374A1 (fr) Nouveau derive de l'isoindolinone, sa preparation et les compositions pharmaceutiques qui le contiennent
DE3060423D1 (en) Dipeptides for use in the treatment of diseases, some compounds of this class, medicaments containing dipeptides and their manufacture
CA2099585A1 (fr) Compositions pharmaceutiques
EA200400691A1 (ru) Получение чистых стереоизомеров трицикло[5,2,1,02,6]дец-9-ил-ксантогената и содержащие их лекарственные средства

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP